Manatt Represents Alliance Global Partners in an Additional $20 Million ATM Offering for FSD Pharma

Manatt’s Thomas Poletti and Katherine Blair, partners in the capital markets group, advised A.G.P./Alliance Global Partners as sales agent in a $20 million at-the-market offering of Class B Subordinate Voting Shares for FSD Pharma Inc., a Canadian company that trades on Nasdaq and the Canadian Securities Exchange.

FSD Pharma, through its wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound FSD-201, by down-regulating the cytokines to effectuate an anti-inflammatory response.

More information about the registered direct offering may be found here.

The Manatt team has previously represented A.G.P. in its role as sales agent in a prior $20 million at-the-market offering, lead placement agent in a $7.5 million private placement and sole placement agent in two registered direct offerings collectively valued at $19.5 million for FSD Pharma Inc.



pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved